AI Science Tracker

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model

Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong 510530, China. · 23 Dec 2024 · medicine

Discovery

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model

Source check: Needs source check. Not independent scientific confirmation.

Finding: Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model. Language and graph neural network models proposed RIPK3 inhibitor candidates, followed by docking and MD filtering. Candidates were checked by docking, ADMET prediction, MD, and in vitro and in vivo (acute ocular hypertension mouse) experiments. Evidence limits: Which model produced the lead and the effect size were not assessed (abstract only); mouse model only. Reviewed from Europe PMC abstract only.

Technology: Large language and graph neural network models for target-compound identification

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Language and graph neural network models proposed RIPK3 inhibitor candidates, followed by docking and MD filtering.
Test and result
Candidates were checked by docking, ADMET prediction, MD, and in vitro and in vivo (acute ocular hypertension mouse) experiments.
Limitation / still unknown
Which model produced the lead and the effect size were not assessed (abstract only); mouse model only.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/39719694

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.